查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930138

全球基因檢測市場：市場規模、市場佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034）

Genetic Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 請詢問到貨日

價格

基因檢測市場成長因子

全球基因檢測市場已成為現代醫學的關鍵支柱，這主要得益於分子生物學的快速發展、疾病盛行率的上升以及個人化醫療的日益普及。根據 Fortune Business Insights 預測，該市場規模預計將在 2025 年達到 373.2 億美元，從 2026 年的 412.2 億美元增長到 2034 年的 939.4 億美元，預測期內複合年增長率 (CAGR) 為 10.85%。

北美地區憑藉其強大的醫療基礎設施、技術領先優勢以及對基因檢測益處的高度認知，在 2025 年佔市場主導地位，市場佔有率為 41.67%。

市場定義與範圍

基因檢測透過分析DNA、染色體或蛋白質來檢測可能促使或增加遺傳疾病風險的基因突變或改變。這些檢測廣泛用於疾病診斷、風險評估、治療方案製定和預防保健。該市場包括用於腫瘤學、產前檢測、藥物基因組學和心臟病等領域的各種產品（儀器和耗材）和服務。

市場驅動因素

慢性病和遺傳病患病率上升

癌症、糖尿病、鐮狀細胞疾病、囊性纖維化和唐氏症等慢性病和遺傳疾病的盛行率上升是市場成長的主要驅動因素。根據世界衛生組織估計，2000年至2021年間，鐮狀細胞疾病患者人數預計將顯著增加，凸顯了早期準確基因診斷的必要性。 此外，人口老化、久坐不動的生活方式和吸菸習慣等因素促使疾病發生率上升，從而推動了對基因檢測的需求。

新產品發布激增

先進診斷測試的持續創新和頻繁的新產品發布正在推動市場擴張。各公司正在腫瘤學、心臟病學和傳染病領域增加高精度檢測的應用。預計主要公司的策略性併購和地理擴張將在預測期內進一步增強市場成長。

市場限制因子

熟練技術人員短缺

熟練實驗室技術人員短缺是主要的限制因素，尤其是在新興經濟體。先進設備的匱乏、培訓不足和實驗室基礎設施不完善阻礙了基因檢測服務的有效應用，為市場成長帶來了挑戰。

市場機會

數位化及與電子健康紀錄 (EHR) 的整合

將基因檢測數據與電子健康記錄 (EHR) 整合，蘊藏著巨大的成長機會。數位化決策支援工具、人工智慧驅動的分析以及基因諮詢聊天機器人正在簡化工作流程，並改善臨床決策。診斷公司與 EHR 供應商之間的合作，確保了檢測申請和結果解讀的無縫銜接，從而改善患者的治療效果。

市場挑戰

監理與倫理問題

基因檢測市場面臨著與資料隱私、知情同意以及潛在的基因歧視相關的複雜監管和倫理挑戰。不同地區的監管框架差異顯著，為製造商和服務提供者帶來了合規方面的複雜性。此外，儘管檢測成本正在下降，但高昂的自付費用仍然限制了成本敏感型市場的普及。

市場趨勢

轉向居家和直接面向消費者（DTC）的偵測

最顯著的趨勢之一是居家和直接面向消費者（DTC）的基因檢測試劑盒日益普及。人們對預防保健意識的提高以及檢測技術的進步正在推動對價格合理、便捷的檢測解決方案的需求。基因數據整合到電子健康記錄（EHR）系統以及個人化醫療的興起進一步推動了這一趨勢。

細分市場分析

  • 依類型劃分：由於全球診斷實驗室數量的增加，服務細分市場正在推動市場成長。受檢測量增加和耗材頻繁使用的影響，產品細分市場將在2026年佔全球市場的48.81%。
  • 依技術劃分：由於其高精度和對精準醫療的適用性，下一代定序（NGS）將佔最大的市場佔有率。 預計到 2026 年，PCR 領域將佔 46.0% 的市場佔有率，這主要得益於臨床應用的不斷增長。
  • 依應用領域劃分：腫瘤領域預計將在 2026 年佔市場主導地位，市場佔有率達到 55.63%，這主要得益於癌症發病率的上升和對早期診斷的需求。

區域展望

  • 北美：預計到 2025 年，北美市場規模將達到 155.5 億美元，其中美國市場預計在 2026 年將達到 156.4 億美元。
  • 歐洲：預計歐洲市場將保持溫和成長，主要得益於研發投入的增加。德國和英國將繼續保持主要貢獻者的地位。
  • 亞太地區：預計中國、日本和印度市場將強勁成長，這主要得益於政府精準醫療計畫的推動，預計亞太地區的複合年增長率 (CAGR) 將最高。
  • 拉丁美洲、中東和非洲：預期成長溫和，主要受醫療保健投資和診斷服務可近性提高的推動。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家主要疾病流行情形（2025 年）
  • 主要公司新產品發布及核准狀況
  • 關鍵產業趨勢：併購、業務合作等
  • 新冠疫情對市場的影響

第五章 全球基因檢測市場分析:考察與預測(2021～2034年)

  • 市場分析、洞察與預測：依類型劃分
    • 產品
      • 設備
      • 耗材
    • 服務
  • 市場分析、洞察與預測：依技術劃分
    • 次世代定序 (NGS)
    • 聚合酶鍊式反應 (PCR)
    • 微陣列
    • 原位雜交
    • 其他
  • 市場分析、洞察與預測：依應用劃分
    • 腫瘤學
    • 產前檢測
    • 藥物基因組學
    • 心臟病
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美基因檢測市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲基因檢測市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲國家

第八章：亞太地區基因檢測市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 韓國
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲基因檢測市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章 中東與非洲基因檢測市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（GCC）國家
    • 南非
    • 其他中東和非洲國家非洲

第11章 競爭分析

  • 世界市場佔有率分析(2025年)
  • 企業簡介
    • Hoffmann-La Roche Ltd.
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc
    • Oxford Nanopore Technologies plc.
    • Laboratory Corporation of America Holdings
    • Agilent Technologies, Inc.
    • Myriad Genetics, Inc.
    • QIAGEN
    • Quest Diagnostics Incorporated.
    • Danaher Corporation
Product Code: FBI105590

Growth Factors of genetic testing Market

The global genetic testing market has emerged as a critical pillar of modern healthcare, driven by rapid advances in molecular biology, rising disease prevalence, and growing adoption of personalized medicine. According to Fortune Business Insights, the market was valued at USD 37.32 billion in 2025 and is projected to grow from USD 41.22 billion in 2026 to USD 93.94 billion by 2034, registering a CAGR of 10.85% during the forecast period.

In 2025, North America dominated the market with a 41.67% share, supported by strong healthcare infrastructure, technological leadership, and high awareness of genetic testing benefits.

Market Definition and Scope

Genetic testing involves the analysis of DNA, chromosomes, or proteins to detect genetic mutations or variations that may cause or increase the risk of inherited disorders. These tests are widely used for disease diagnosis, risk assessment, treatment planning, and preventive healthcare. The market comprises products (equipment and consumables) and services, catering to applications such as oncology, prenatal testing, pharmacogenomics, cardiology, and others.

Market Drivers

Rising Prevalence of Chronic and Genetic Disorders

The increasing burden of chronic and genetic diseases such as cancer, diabetes, sickle cell disease, cystic fibrosis, and Down syndrome is a major driver of market growth. According to global health estimates, the number of individuals living with sickle cell disease rose significantly between 2000 and 2021, highlighting the growing need for early and accurate genetic diagnosis. Additionally, the rising elderly population, sedentary lifestyles, and tobacco exposure are contributing to higher disease incidence, thereby boosting demand for genetic testing.

Surge in New Product Launches

Continuous innovation and frequent launches of advanced diagnostic tests are accelerating market expansion. Companies are increasingly introducing high-precision tests for oncology, cardiology, and infectious diseases. Strategic mergers, acquisitions, and geographic expansion by leading players further strengthen market growth during the forecast period.

Market Restraints

Shortage of Skilled Professionals

A key restraining factor is the shortage of skilled laboratory technologists, especially in emerging economies. Limited access to advanced equipment, insufficient training, and inadequate laboratory infrastructure restrict the effective adoption of genetic testing services, posing challenges to market growth.

Market Opportunities

Digitalization and EHR Integration

The integration of genetic testing data with Electronic Health Records (EHRs) presents a significant growth opportunity. Digital decision-support tools, AI-enabled analytics, and genetic counseling chatbots are streamlining workflows and improving clinical decision-making. Collaborations between diagnostic companies and EHR vendors enable seamless test ordering and result interpretation, enhancing patient outcomes.

Market Challenges

Regulatory and Ethical Concerns

The genetic testing market faces complex regulatory and ethical challenges related to data privacy, informed consent, and potential genetic discrimination. Regulatory frameworks vary significantly across regions, creating compliance complexities for manufacturers and service providers. Additionally, despite declining test costs, high out-of-pocket expenses continue to limit adoption in cost-sensitive markets.

Market Trends

Shift Toward At-Home and DTC Testing

One of the most prominent trends is the growing adoption of at-home and direct-to-consumer (DTC) genetic testing kits. Increased awareness of preventive healthcare and advancements in testing technologies have fueled demand for affordable, convenient testing solutions. Integration of genetic data into EHR systems and the rise of personalized medicine further support this trend.

Segmentation Analysis

  • By Type: The services segment dominated the market due to the rising number of diagnostic laboratories worldwide. The product segment, contributing 48.81% globally in 2026, benefits from increased testing volumes and frequent consumable usage.
  • By Technique: Next-Generation Sequencing (NGS) holds the largest share owing to its high accuracy and suitability for precision medicine. The PCR segment accounts for 46.0% market share in 2026, driven by widespread clinical adoption.
  • By Application: The oncology segment dominated with a 55.63% share in 2026, supported by the rising prevalence of cancer and demand for early diagnosis.

Regional Outlook

  • North America: Valued at USD 15.55 billion in 2025, with the U.S. market reaching USD 15.64 billion in 2026.
  • Europe: Moderate growth supported by R&D investments; Germany and the UK remain key contributors.
  • Asia Pacific: Expected to grow at the highest CAGR, with China, Japan, and India showing strong expansion due to government precision-medicine initiatives.
  • Latin America & Middle East & Africa: Gradual growth driven by healthcare investments and improving diagnostic access.

Competitive Landscape

The market is partially consolidated, with major players including Hoffmann-La Roche Ltd., Illumina, Inc., QIAGEN, and Quest Diagnostics Incorporated. These companies focus on innovation, strategic collaborations, and portfolio expansion to maintain competitive advantage.

Conclusion

In conclusion, the global genetic testing market is set for robust growth from USD 37.32 billion in 2025 to USD 93.94 billion by 2034, driven by technological advancements, rising disease prevalence, and increasing adoption of personalized medicine. While regulatory complexities and workforce shortages pose challenges, ongoing innovation, digital integration, and expanding healthcare access are expected to sustain long-term market expansion and transform the future of precision diagnostics.

Segmentation By Type

  • Products
    • Equipment
    • Consumables
  • Services

By Technique

  • Next-generation Sequencing (NGS)
  • Polymerase Chain Reaction
  • Microarrays
  • In-situ Hybridization
  • Others

By Application

  • Oncology
  • Prenatal Testing
  • Pharmacogenomics
  • Cardiology
  • Others

By Region

  • North America (By Type, Technique, Application, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Technique, Application, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Technique, Application, and Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Technique, Application, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Technique, Application, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries, 2025
  • 4.2. New Product Launches/ Approvals, By Key Players
  • 4.3. Key Industry Developments- Mergers, Partnerships, Acquisitions, etc.
  • 4.4. Impact of COVID-19 on the Market

5. Global Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Products
      • 5.1.1.1. Equipment
      • 5.1.1.2. Consumables
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Technique
    • 5.2.1. Next-generation Sequencing (NGS)
    • 5.2.2. Polymerase Chain Reaction
    • 5.2.3. Microarrays
    • 5.2.4. In-situ Hybridization
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Oncology
    • 5.3.2. Prenatal Testing
    • 5.3.3. Pharmacogenomics
    • 5.3.4. Cardiology
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Products
      • 6.1.1.1. Equipment
      • 6.1.1.2. Consumables
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Technique
    • 6.2.1. Next-generation Sequencing (NGS)
    • 6.2.2. Polymerase Chain Reaction
    • 6.2.3. Microarrays
    • 6.2.4. In-situ Hybridization
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Oncology
    • 6.3.2. Prenatal Testing
    • 6.3.3. Pharmacogenomics
    • 6.3.4. Cardiology
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Products
      • 7.1.1.1. Equipment
      • 7.1.1.2. Consumables
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Technique
    • 7.2.1. Next-generation Sequencing (NGS)
    • 7.2.2. Polymerase Chain Reaction
    • 7.2.3. Microarrays
    • 7.2.4. In-situ Hybridization
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Oncology
    • 7.3.2. Prenatal Testing
    • 7.3.3. Pharmacogenomics
    • 7.3.4. Cardiology
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandianvia
    • 7.4.7. Rest of Europe

8. Asia Pacific Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Products
      • 8.1.1.1. Equipment
      • 8.1.1.2. Consumables
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Technique
    • 8.2.1. Next-generation Sequencing (NGS)
    • 8.2.2. Polymerase Chain Reaction
    • 8.2.3. Microarrays
    • 8.2.4. In-situ Hybridization
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Oncology
    • 8.3.2. Prenatal Testing
    • 8.3.3. Pharmacogenomics
    • 8.3.4. Cardiology
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. China
    • 8.4.2. India
    • 8.4.3. Japan
    • 8.4.4. South Korea
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Products
      • 9.1.1.1. Equipment
      • 9.1.1.2. Consumables
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Technique
    • 9.2.1. Next-generation Sequencing (NGS)
    • 9.2.2. Polymerase Chain Reaction
    • 9.2.3. Microarrays
    • 9.2.4. In-situ Hybridization
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Oncology
    • 9.3.2. Prenatal Testing
    • 9.3.3. Pharmacogenomics
    • 9.3.4. Cardiology
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Products
      • 10.1.1.1. Equipment
      • 10.1.1.2. Consumables
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Technique
    • 10.2.1. Next-generation Sequencing (NGS)
    • 10.2.2. Polymerase Chain Reaction
    • 10.2.3. Microarrays
    • 10.2.4. In-situ Hybridization
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Oncology
    • 10.3.2. Prenatal Testing
    • 10.3.3. Pharmacogenomics
    • 10.3.4. Cardiology
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Hoffmann-La Roche Ltd.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Illumina, Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Thermo Fisher Scientific Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Bio-Rad Laboratories, Inc
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Oxford Nanopore Technologies plc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Laboratory Corporation of America Holdings
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Agilent Technologies, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Myriad Genetics, Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. QIAGEN
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Quest Diagnostics Incorporated.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Danaher Corporation
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 4: Global Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Genetic Testing Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 7: North America Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 8: North America Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 9: North America Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 10: North America Genetic Testing Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 12: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 13: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 14: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 17: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 18: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 19: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 20: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Products 2021-2034
  • Table 23: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 24: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 25: Latin America Genetic Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 27: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 28: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 29: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 30: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Genetic Testing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Genetic Testing Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Genetic Testing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 4: Global Genetic Testing Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Genetic Testing Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 8: North America Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 9: North America Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 10: North America Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 11: North America Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 12: North America Genetic Testing Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Genetic Testing Market Value Share (%), By Country, 2025
  • Figure 14: Europe Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 16: Europe Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 17: Europe Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 18: Europe Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 19: Europe Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 20: Europe Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 25: Asia Pacific Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 26: Asia Pacific Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 27: Asia Pacific Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 28: Asia Pacific Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 33: Latin America Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 34: Latin America Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 35: Latin America Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 36: Latin America Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 41: Middle East & Africa Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 42: Middle East & Africa Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 43: Middle East & Africa Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 44: Middle East & Africa Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Genetic Testing Market Share (%), By Company, 2025